Technical Analysis for NXS - Next Science Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.00% | |
| 20 DMA Support | Bullish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Crossed Above 20 DMA | Bullish | -2.56% |
| Alert | Time |
|---|---|
| Reversed from Down | about 4 hours ago |
| 50 DMA Support | about 7 hours ago |
| Down 1 ATR | about 7 hours ago |
| Fell Below Previous Day's Low | about 7 hours ago |
| 20 DMA Support | about 7 hours ago |
Get a Trading Assistant
Next Science Limited Description
Next Science Limited is an Australia-based medical technology company. The Company focuses on the development and commercialization of its Xbio technology to reduce the impact of biofilm-based infections in human health. Its products include Bactisure Surgical Lavage, BlastX Antimicrobial Wound Gel, TorrentX Wound Wash, SurgX Sterile Antimicrobial Wound Gel for Surgical Site Infections and Acne Treatment. The SurgX is a surgical gel designed to help reduce superficial surgical site infections (SSIs) and protect wound tissue to facilitate natural healing. Its Bactisure is designed to remove structurally resistant forms of bacteria (biofilm) through physical deconstruction of the extracellular polymeric substance (EPS) matrix, making bacteria more susceptible to traditional antibiotics and the body’s normal defense mechanisms. BlastX is an antimicrobial wound gel and deconstructs the bacterial biofilm, the gel envelops and eliminates the bacteria.
Classification
Sector: Basic Materials
Industry: Independent Oil & Gas
Keywords: Health Construction Biology Medical Technology Sms Film Infection Bacteria Wound Bacteriology Microbiology Antibiotic Acne Antibiotics Antimicrobial Healing Infections Bio Technology Environmental Microbiology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.665 |
| 52 Week Low | 0.18 |
| Average Volume | 119,344 |
| 200-Day Moving Average | 0.384 |
| 50-Day Moving Average | 0.363 |
| 20-Day Moving Average | 0.367 |
| 10-Day Moving Average | 0.351 |
| Average True Range | 0.023 |
| RSI (14) | 55.16 |
| ADX | 19.41 |
| +DI | 35.762 |
| -DI | 21.413 |
| Chandelier Exit (Long, 3 ATRs) | 0.402 |
| Chandelier Exit (Short, 3 ATRs) | 0.378 |
| Upper Bollinger Bands | 0.448 |
| Lower Bollinger Band | 0.286 |
| Percent B (%b) | 0.58 |
| BandWidth | 44.106 |
| MACD Line | 0.002 |
| MACD Signal Line | -0.002 |
| MACD Histogram | 0.0039 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.410 | ||||
| Resistance 3 (R3) | 0.410 | 0.400 | 0.405 | ||
| Resistance 2 (R2) | 0.400 | 0.392 | 0.400 | 0.403 | |
| Resistance 1 (R1) | 0.390 | 0.388 | 0.390 | 0.390 | 0.402 |
| Pivot Point | 0.380 | 0.380 | 0.380 | 0.380 | 0.380 |
| Support 1 (S1) | 0.370 | 0.372 | 0.370 | 0.370 | 0.358 |
| Support 2 (S2) | 0.360 | 0.368 | 0.360 | 0.357 | |
| Support 3 (S3) | 0.350 | 0.360 | 0.355 | ||
| Support 4 (S4) | 0.350 |
